/ERMA.ST
ERMA.ST Stock - Enorama Pharma AB (publ)
Healthcare|Drug Manufacturers - Specialty & GenericSTO
$2.30+0.88%
+$0.02 (+0.88%) • Dec 23
50
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.53
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.53
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ERMA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.28 – $2.32
TARGET (TP)$2.64
STOP LOSS$2.12
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.67
52W High$3.80
52W Low$1.51
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $15.77M | $1.36M | $6.85M | $11.04M | $2.15M |
| Gross Profit | $3.70M | $-3,901,000 | $-616,000 | $2.13M | $2.37M |
| Gross Margin | 23.5% | -287.3% | -9.0% | 19.3% | 110.2% |
| Operating Income | $-47,515,000 | $-41,838,000 | $-41,470,000 | $-26,940,000 | $-23,011,000 |
| Net Income | $-43,806,000 | $-44,613,000 | $-41,780,000 | $-28,544,000 | $-23,901,000 |
| Net Margin | -277.8% | -3285.2% | -610.2% | -258.6% | -1113.7% |
| EPS | $-0.83 | $-1.33 | $-4.40 | $-3.80 | $-3.54 |
Company Overview
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ERMA.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.36
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.36 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.12 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.14 | — | — |
Q2 2024 | Jun 27, 2024 | — | $-0.19 | — | — |
Q1 2024 | Mar 4, 2024 | — | $-0.32 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.29 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.25 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.33 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-1.28 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-1.06 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-1.42 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-1.42 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.07 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-1.33 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.89 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-2.19 | — | — |
Q4 2020 | Nov 11, 2020 | — | $-0.34 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.88 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.83 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ERMA.ST
What is ERMA.ST's current stock price?
Enorama Pharma AB (publ) (ERMA.ST) is currently trading at $2.30 per share. The stock has moved +0.88% today.
What is the analyst price target for ERMA.ST?
No analyst price targets are currently available for this stock.
What sector is Enorama Pharma AB (publ) in?
Enorama Pharma AB (publ) operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the STO exchange.
What is ERMA.ST's market cap?
Enorama Pharma AB (publ) has a market capitalization of $0.17 billion, making it a small-cap company.
Does ERMA.ST pay dividends?
No, Enorama Pharma AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUC.ST
AcuCort AB
$0.57
Mkt Cap: $0.1B
ALZCUR.ST
AlzeCure Pharma AB (publ)
$2.08
Mkt Cap: $0.2B
ANNX.ST
Annexin Pharmaceuticals AB (publ)
$19.00
Mkt Cap: $0.1B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
INTEG-B.ST
Integrum AB (publ)
$10.06
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
IZAFE-B.ST
iZafe Group AB (publ)
$0.47
Mkt Cap: $0.1B
KLAR.ST
Klaria Pharma Holding AB (publ.)
$0.61
Mkt Cap: $0.2B
SENZA.ST
SenzaGen AB
$5.98
Mkt Cap: $0.2B
VIVE.ST
Vivesto AB
$0.14
Mkt Cap: $0.1B
Explore stocks similar to ERMA.ST for comparison